Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Product Type

  2.3.2 Market Size By Modality

  2.3.3 Market Size By Clinical Service

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO's Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter's) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1. Mo-99 Reactor & Cyclotron Producers

  3.4.2. Generator & Kit Manufacturers

  3.4.3. Nuclear Pharmacies & Distributors

  3.4.4. Hospitals, Imaging Centers & End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Supply & Production Metrics

  4.1.1 Reactor & Cyclotron Capacity Utilization

  4.1.2 Mo-99 to Tc-99m Yield Benchmarks

  4.1.3 Supply Disruption & Outage History

  4.1.4 Import & Export Volume Trends

 4.2 Regulatory & Clinical Pathways

  4.2.1 Generator & Kit Approval Timelines

  4.2.2 SPECT/CT Equipment Clearance Activity

  4.2.3 Clinical Guideline & Reimbursement Coverage

  4.2.4 Radioactive-Material Licensing Requirements

 4.3 Procurement & Distribution Statistics

  4.3.1 Nuclear Pharmacy Network Density

  4.3.2 Hospital Contract & Pricing Structures

  4.3.3 Generator Delivery & Logistics Cycle Times

  4.3.4 Distributor Consolidation Trends

 4.4 Clinical Demand Context

  4.4.1 Cardiac Perfusion Imaging Volumes

  4.4.2 Neurology & Oncology Referral Trends

  4.4.3 Disease Prevalence & Aging-Population Data

  4.4.4 Outpatient vs. Hospital Site-of-Care Shift

 4.5 Innovation & Investment Outcomes

  4.5.1 Non-Reactor Production Investment

  4.5.2 Power-Reactor & Cyclotron Partnerships

  4.5.3 New SPECT Hardware Launches

  4.5.4 Mergers, Acquisitions & Divestitures

5. Technetium-99m Market Segmental Analysis, By Product Type

 5.1 Introduction

 5.2 Technetium-99m Generators

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Radiopharmaceutical Kits

 5.4 Ready-to-Use Radiopharmaceuticals

 5.5 Cyclotron-Produced Tc-99m

6. Technetium-99m Market Segmental Analysis, By Modality

 6.1 Introduction

 6.2 Gamma Camera

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 SPECT

7. Technetium-99m Market Segmental Analysis, By Clinical Service

 7.1 Introduction

 7.2 Cardiac Scans

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Bone Scans

 7.4 Renal Scans

 7.5 Neurology Scans

 7.6 Pulmonary Scans

 7.7 Thyroid Scans

 7.8 Others

8. Technetium-99m Market Segmental Analysis, By End User

 8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Diagnostic Imaging Centers

 8.4 Nuclear Medicine Centers

 8.5 Ambulatory Surgical Centers

 8.6 Others

9. Technetium-99m Market Segmental Analysis, By Region

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 Technetium-99m Market Size & Forecast, By Product Type, 2022–2035

  9.2.3 Technetium-99m Market Size & Forecast, By Modality, 2022–2035

  9.2.4 Technetium-99m Market Size & Forecast, By Clinical Service, 2022–2035

  9.2.5 Technetium-99m Market Size & Forecast, By End User, 2022–2035

  9.2.6 Technetium-99m Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 US

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 Technetium-99m Market Size & Forecast, By Product Type, 2022–2035

  9.3.3 Technetium-99m Market Size & Forecast, By Modality, 2022–2035

  9.3.4 Technetium-99m Market Size & Forecast, By Clinical Service, 2022–2035

  9.3.5 Technetium-99m Market Size & Forecast, By End User, 2022–2035

  9.3.6 Technetium-99m Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 France

   9.3.6.3 UK

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Poland

   9.3.6.7 Russia

   9.3.6.8 Rest of Europe

 9.4 Asia Pacific

  9.4.1 Key Trends

  9.4.2 Technetium-99m Market Size & Forecast, By Product Type, 2022–2035

  9.4.3 Technetium-99m Market Size & Forecast, By Modality, 2022–2035

  9.4.4 Technetium-99m Market Size & Forecast, By Clinical Service, 2022–2035

  9.4.5 Technetium-99m Market Size & Forecast, By End User, 2022–2035

  9.4.6 Technetium-99m Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 Technetium-99m Market Size & Forecast, By Product Type, 2022–2035

  9.5.3 Technetium-99m Market Size & Forecast, By Modality, 2022–2035

  9.5.4 Technetium-99m Market Size & Forecast, By Clinical Service, 2022–2035

  9.5.5 Technetium-99m Market Size & Forecast, By End User, 2022–2035

  9.5.6 Technetium-99m Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 Technetium-99m Market Size & Forecast, By Product Type, 2022–2035

  9.6.3 Technetium-99m Market Size & Forecast, By Modality, 2022–2035

  9.6.4 Technetium-99m Market Size & Forecast, By Clinical Service, 2022–2035

  9.6.5 Technetium-99m Market Size & Forecast, By End User, 2022–2035

  9.6.6 Technetium-99m Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 Curium Pharma

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 GE HealthCare Technologies Inc.

  10.6.3 Jubilant Pharmova Limited

  10.6.4 NTP Radioisotopes SOC Ltd.

  10.6.5 Bracco Imaging S.p.A.

  10.6.6 Institute of Isotopes Co., Ltd.

  10.6.7 ANSTO

  10.6.8 NCBJ POLATOM

  10.6.9 ARTMS Inc.

  10.6.10 China Isotope & Radiation Corporation

  10.6.11 Eczacıbaşı-Monrol Nuclear Products

  10.6.12 Eckert & Ziegler SE

  10.6.13 Isotopia Molecular Imaging Ltd.

  10.6.14 Medi-Radiopharma Ltd.

  10.6.15 Rotop Pharmaka GmbH

  10.6.16 NRG PALLAS

  10.6.17 Institute for Radioelements (IRE)

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures